Skip to main content

Peer Review reports

From: VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

Original Submission
20 Nov 2017 Submitted Original manuscript
4 Dec 2017 Author responded Author comments - Maurizio Martini
Resubmission - Version 2
4 Dec 2017 Submitted Manuscript version 2
19 Dec 2017 Author responded Author comments - Maurizio Martini
Resubmission - Version 3
19 Dec 2017 Submitted Manuscript version 3
13 Feb 2018 Reviewed Reviewer Report - Anindita Chakrabarty
23 Feb 2018 Reviewed Reviewer Report - Margaritis Avgeris
14 Mar 2018 Author responded Author comments - Maurizio Martini
Resubmission - Version 4
14 Mar 2018 Submitted Manuscript version 4
9 Apr 2018 Author responded Author comments - Maurizio Martini
Resubmission - Version 5
9 Apr 2018 Submitted Manuscript version 5
24 Apr 2018 Author responded Author comments - Maurizio Martini
Resubmission - Version 6
24 Apr 2018 Submitted Manuscript version 6
Publishing
26 Apr 2018 Editorially accepted
10 May 2018 Article published 10.1186/s12885-018-4442-2

You can find further information about peer review here.

Back to article page